Jefferson University Hospitals

Gastrointestinal Motility Program

Related Content
gastrointestinalmotilityprogram
  • Among the Nation's Best for Gastroenterology & GI Surgery
    Among the Nation's Best for Gastroenterology & GI Surgery
    U.S.News & World Report rated us among the nation's best for Gastroenterology & GI Surgery.
    Learn More >

Jefferson's Gastrointestinal Motility Program offers a broad range of advanced diagnostic capabilities to help accurately diagnose motility disorders. The Program has a proven track record of performing reliable testing for a large volume of patients.

Diagnosing Motility Disorders

Among the diagnostic procedures available in the Gastrointestinal Motility Program are:

  • 24-Hour ambulatory pH monitoring is considered the "gold standard" for diagnosing gastroesophageal reflux disease (GERD). This test is particularly useful if you present with atypical symptoms, such as noncardiac chest pain, laryngitis, asthma and other respiratory disorders. It may also be used to assess your response to therapy. Our state-of-the-art system allows for the simultaneous assessment of proximal esophageal, distal esophageal and gastric pH to accurately measure the degree of acid reflux.
  • Esophageal manometry is the test of choice for diagnosing motility disorders that cause difficulty swallowing. It is also used to identify esophageal causes of noncardiac chest pain and to assess esophageal motility if you are diagnosed with GERD, collagen-vascular diseases, diabetes mellitus or neuromuscular disorders. Our advanced system allows us to study the upper esophageal sphincter and swallowing mechanisms, as well as the lower esophageal sphincter and esophageal body, without the drawbacks of older water-perfused systems.
  • Tensilon provocative testing is performed in conjunction with esophageal manometry to identify an esophageal cause of noncardiac chest pain.
  • Bernstein testing (acid infusion testing) can be useful in confirming that GERD is the cause of your chest pain.
  • Anorectal motility testing enables the diagnosis of anorectal sensorimotor dysfunction if you are complaining of constipation, fecal incontinence or abdominal pain. It also provides valuable information about the clinical outcome of surgical candidates who may be at risk of manifesting incontinence after surgery.
  • Anorectal biofeedback therapy has been successful in treating more than 90 percent of patients with complaints of fecal incontinence or pelvic floor dyssynergia. This test helps assess motility disorders of the biliary system that can cause abdominal pain and is performed as part of an endoscopic retrograde cholangiopancreatography (ERCP).

Program Leadership